Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?

Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease

(2011) Xavier Rousset et al.   Current Opinion in Endocrinology Diabetes and Obesity

Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib

(2010) Laurent Yvan-Charvet et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High Pre- 1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol

(2010) A. A. Sethi et al.   CLINICAL CHEMISTRY

5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice

(2010) M. J. A. Amar et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation

(2010) L. Yvan-Charvet et al.   SCIENCE

Acyl-coenzyme A:cholesterol acyltransferases

(2009) Ta-Yuan Chang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men

(2009) R.P.F. Dullaart et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans

(2009) L. Calabresi et al.   CIRCULATION

Lecithin: Cholesterol Acyltransferase and Atherosclerosis

(2009) Daniel J. Rader   CIRCULATION

Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo

(2009) Hiroyuki Tanigawa et al.   CIRCULATION

Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions

(2009) E Van Craeyveld et al.   GENE THERAPY

Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein

(2009) Marcelo J.A. Amar et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

High-density lipoprotein/apolipoprotein A-I infusion therapy

(2008) Jean-Claude Tardif et al.   Current Atherosclerosis Reports

Plasma Lecithin: Cholesterol Acyltransferase Activity Is Elevated in Metabolic Syndrome and Is an Independent Marker of Increased Carotid Artery Intima Media Thickness

(2008) Robin P. F. Dullaart et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM